Drugs / Neuromultivit
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02508805 | May → Sep 2015 | radiculopathy | Bausch Health Americas, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neuromultivit | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02508805 ↗ |
| Route | Intramuscular | “Neuromultivit (2 ml per day, i.m.)” NCT02508805 ↗ |